Respiratory Devices And Equipment (Diagnostic) Market Size Reaches $9.18 Billion In 2026: What Is Driving Growth?
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Respiratory Devices And Equipment (Diagnostic) Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The market size for respiratory devices and equipment (diagnostic) has seen strong growth in recent years. This market is projected to expand from $8.36 billion in 2025 to $9.18 billion in 2026, at a compound annual growth rate (CAGR) of 9.8%. The historical growth can be linked to the increasing occurrence of respiratory disorders, the expansion of pulmonary diagnostic laboratories, a rising need for early disease diagnosis, the availability of sophisticated spirometry devices, and the increasing application of oxygen monitoring tools.
The market size for respiratory devices and equipment (diagnostic) is projected to experience substantial growth in the upcoming years. Its valuation is anticipated to reach $13.29 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.7%. This expansion during the forecast period stems from escalating investments in the diagnosis of respiratory diseases, the wider embrace of molecular and imaging-based tests, the growth of home-based diagnostic monitoring, a heightened emphasis on individualized respiratory care, and continuous advancements in diagnostic assay development. Key developments expected in this period encompass the increased use of portable diagnostic respiratory devices, a rise in the application of molecular diagnostic tests for respiratory conditions, the expanding incorporation of AI-powered lung function analysis, the broader availability of point-of-care respiratory testing, and a stronger emphasis on identifying diseases early.
Get A Free Sample Report With In-Depth Market Insights:
Respiratory Devices And Equipment (Diagnostic) Market Growth Catalysts And Demand Drivers
The anticipated expansion of the respiratory devices and equipment (diagnostic) market is linked to the rising occurrence of different respiratory ailments. These conditions are health issues impacting the lungs and air passages, hindering regular respiration and oxygen transfer, often caused by inflammation, infections, blockages, or lasting structural damage. The increasing incidence of diverse respiratory illnesses stems from a global rise in conditions that gradually diminish lung capacity, making populations more susceptible to enduring respiratory problems. Such equipment and devices assist in managing respiratory diseases through improving air circulation, boosting oxygen supply, and allowing for more precise monitoring of lung health to stabilize patients. As an illustration, in June 2025, the World Health Organization, an entity based in Switzerland, reported that 81.7 million people are currently affected by chronic respiratory diseases, with an additional 6.8 million receiving a new diagnosis annually. Consequently, the growing prevalence of a range of respiratory diseases fuels the respiratory devices and equipment (diagnostic) market.
Respiratory Devices And Equipment (Diagnostic) Market Segment Analysis: What Are The Core Market Categories?
The respiratory devices and equipment (diagnostic) market covered in this report is segmented –
1) By Product: Instruments And Devices, Assays And Reagents
2) By Test Type: Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests
3) By Disease Type: Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis, Other Diseases
4) By End User: Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories, Other End Users
Subsegments:
1) By Instruments And Devices: Spirometers, Pulse Oximeters, Peak Flow Meters, Capnographs, Respiratory Pressure Monitors, Portable Ventilators
2) By Assays And Reagents: Diagnostic Kits, Reagents For Respiratory Infections, Blood Gas Analysis Reagents, PCR Assays For Respiratory Pathogens
Respiratory Devices And Equipment (Diagnostic) Market Trends Shaping Long-Term Demand
Major companies operating in the respiratory devices and equipment (diagnostic) market are channeling their efforts into developing advanced diagnostic solutions, including automated nucleic acid purification instruments and the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, to enhance the precision and speed of viral detection. Automated nucleic acid purification instruments and the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit facilitate the swift and reliable isolation of viral genetic material for accurate diagnostic assessments. As an illustration, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, introduced Sample Preparation Solutions for Respiratory Diagnostic Testing. The Thermo Scientific KingFisher Apex Dx automates the purification of up to 24 or 96 samples of DNA, RNA, protein, or cells, ensuring high-quality results for respiratory testing. This system functions alongside the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, presenting a comprehensive solution for in vitro diagnostics. Featuring sophisticated data management and cybersecurity, the system supports uninterrupted workflows from sample preparation to real-time PCR analysis, applicable for both research and diagnostic purposes.
Respiratory Devices And Equipment (Diagnostic) Market Key Participants And Competitive Landscape
Major companies operating in the respiratory devices and equipment (diagnostic) market are ResMed Inc., Medtronic plc, Masimo Corporation, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Chart Industries Inc., Philips Healthcare, Becton Dickinson and Company (BD), Abbott Laboratories, Thermo Fisher Scientific Inc., Teleflex Incorporated, Invacare Corporation, Vyaire Medical Inc., Drägerwerk AG & Co. KGaA, Getinge AB, Dräger Medical GmbH, bioMérieux, Bio-Rad Laboratories Inc – Bio-Rad Laboratories Inc., Cosmed S.r.l., Seegene Inc., SDI Diagnostics, GlaxoSmithKline plc, Hillrom, Hamilton Medical AG, Medline Industries Inc., 3M Company, Air Liquide, Allied Healthcare Products Inc., Armstrong Medical, Bio-Med Devices Inc., Breas Medical AB, CAIRE Inc., DeVilbiss Healthcare, Nihon Kohden Corporation, O2 Concepts LLC
View The Full Respiratory Devices And Equipment (Diagnostic) Market Report:
Respiratory Devices And Equipment (Diagnostic) Market Geographic Analysis: Where Is Demand Rising Fastest?
Asia-Pacific was the largest region in the respiratory devices and equipment (diagnostic) market in 2025. North America was the second largest region in the respiratory devices and equipment (diagnostic) market. The regions covered in the respiratory devices and equipment (diagnostic) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
